Trademark Search in Canada

NUQLARIS

View On IC.GC.CA

ABANDONED SECTION 36

on 15 Dec 2020

Last Applicant/ Owned by

ALKERMES PHARMA IRELAND LIMITED

Connaught House 1 Burlington Road Dublin

Serial Number

1899194 filed on 15^th May 2018

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

M4T1X3

NUQLARIS

Trademark usage description

pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major d Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia.

Classification kind code

Mark Details

Serial Number

1899194

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 6 on 15^th Dec 2020	Abandoned - Section 36
Submitted for opposition 14 on 22^nd Sept 2020	Default Notice Sent
Submitted for opposition 22 on 15^th Jan 2020	Search Recorded
Submitted for opposition 20 on 15^th Jan 2020	Examiner's First Report
Submitted for opposition 31 on 18^th May 2018	Formalized
Submitted for opposition 30 on 15^th May 2018	Filed
Submitted for opposition 1 on 15^th May 2018	Created